483 Janssen Pharmaceutica, N.V. Jun 2018

483 Janssen Pharmaceutica, N.V. Jun 2018

Jose Cruz Gonzalez FDA$119.00 - Available Now

FDA investigators audited the Janssen Pharmaceutica, N.V. - Beerse, Belgium facility and issued inspectional observations (via FDA 483) on 12 Jun 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 12 Jun 2018
  • Location: Beerse, Belgium
  • FEI: 3002807336
Add To Cart